Back to Sumitomo Mitsui Trust Group, Inc. Sumitomo Mitsui Trust Group, Inc.

NRIXNRIX
8 quarters

Position history for Sumitomo Mitsui Trust Group, Inc.Sumitomo Mitsui Trust Group, Inc.'s holdings in NURIX THERAPEUTICS INC

Sumitomo Mitsui Trust Group, Inc. holds 983,462 shares of NRIX (NURIX THERAPEUTICS INC), worth $23.9M as of 2026-Q2. The position was decreased (-16.7% shares). NRIX represents 0.0% of Sumitomo Mitsui Trust Group, Inc.'s portfolio.

Current Value

$23.9M

Current Shares

983,462

Total Value Change

+$11.4M

Total Shares Change

+430,211

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
983,462
-16.7%
$23.9M0.0%$24.26
0
2026-Q1
Decreased
1.2M
-8.5%
$18.3M0.0%$15.81
0
2025-Q4
Decreased
1.3M
-17.1%
$24.5M0.0%$19.02
0
2025-Q3
Increased
1.6M
+11.9%
$14.4M0.0%$9.28
31
2025-Q2
Increased
1.4M
+84.1%
$15.9M0.0%$11.64
44
2025-Q1
Decreased
755,970
-4.2%
$9M0.0%$12.15
0
2024-Q4
Increased
789,222
+42.6%
$14.9M0.0%$18.64
38
2024-Q3
New
553,251
-
$12.4M0.0%$23.05
39

Other major holders of NRIX: BlackRock, Inc., FMR LLC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used